Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,340.00    -116.00 (-2.60%)
Bid:
4,296.00
Ask:
4,376.00
Spread: 80.00 (1.862%)
Market Cap: £4.55b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Interim Management Statement

14 May 2010 08:51

RNS Number : 9274L
Computacenter PLC
14 May 2010
Ā 



Interim Management Statement

Ā 

14th May 2010

Ā 

Computacenter plc, the independent IT services provider, is today holding its Annual General Meeting and publishes its Interim Management Statement based on unaudited financial information, for the period from 1 January 2010 to date.

Ā 

Financial Performance

Ā 

Group revenue, for the first quarter, increased by 7% to £634.4m on an as reported basis, which includes the effects of disposals, acquisitions and small currency movements. Excluding these effects, Group revenue for the first quarter increased by 8% to £616.0m and has seen similar growth rates in Q2 to date. Our Services revenue grew by 2% in Q1, and we have seen a small increase in this growth in Q2 to date. Group product revenue grew by 9% in Q1, including disposals, acquisitions and currency movements and by 12% excluding these effects and the growth has been maintained in Q2.

Ā 

We have managed to achieve these growth rates with further reductions compared to Q1 2009, albeit small, to our cost base from last year's cost reduction program without exceptional costs.Ā 

Ā 

In the UK, we have seen a strong rebound in product sales, with growth of 20% excluding the disposal of CCD. This growth was flattered by one large project, which is not ongoing. However, excluding this project, the underlying growth rate was still greater than 10%, which has been maintained in Q2. UK services grew by 3% in Q1 and has increased further in Q2, due to new business gains.

Ā 

As previously reported, we had a slow start to the year in Germany, but there was a material pick up in March. In the first quarter as a whole, product revenues grew 12% but only 1% if the acquisition of becom is excluded. Services declined by 3%, which was not materially affected by the acquisition. The improved trading in March has continued into Q2.

Ā 

In France, the first quarter services revenue increased by 13% and product revenue by 7%. However, gross margins are lower than in Q1 2009, which was an artificially high position. Q2 to date has seen a similar trading performance to Q1.Ā 

Ā 

Financial Position

Ā 

Despite the growth in our product business, our balance sheet continues to strengthen. At the end of Q1, net cash, excluding Customer Specific Financing (CSF), was approximately £89m (£86m at the end of Q4 2009). Net Funds including CSF was £53.3m (£37.3m at the end of Q4 2009). This position is still benefitting from an extended credit scheme with one of our major vendors, to the extent of approximately £30 million. There is no material change in this position since the end of Q1, despite the cash cost of paying the additional interim dividend totalling £11.8 million on 1 April 2010.

Ā 

Outlook

Ā 

After a challenging 2009 for our product business, we saw a strong rebound in Q1 2010, particularly in the UK. Whilst it is not certain that these growth rates can be maintained throughout the year, the signs are encouraging. Our services business has seen slower growth than we have become used to, but we are expecting this to improve as the year progresses. After a slow start to the year, our German business is showing some improvement. Trading this year to date across the Group has increased our confidence of another year of progress for Computacenter, in line with management expectations.Ā 

Ā 

Our next scheduled trading update will be the pre-close briefing prior to our Interim Results, which is scheduled for 13th July 2010.

Ā 

Enquiries

Ā 

Computacenter plc

Ā 

Mike Norris, Chief Executive 01707 631601

Ā 

Tony Conophy, Finance Director 01707 631515

Ā 

Tessa Freeman, PR Manager 01707 631514

Ā 

Tulchan Communications 020 7353 4200

Ā 

Andrew Grant

Ā 

Stephen Malthouse

Ā 

Ā 

Ā 

Ā 

Ā 

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
IMSUSSBRRSAVARR
Date   Source Headline
1st Aug 20246:03 pmRNSTransaction in Own Shares
1st Aug 202412:00 pmRNSTotal Voting Rights
1st Aug 202410:15 amRNSDirector/PDMR Shareholding
1st Aug 202410:15 amRNSDirector/PDMR Shareholding
31st Jul 20246:21 pmRNSTransaction in Own Shares
30th Jul 20246:22 pmRNSTransaction in Own Shares
30th Jul 202410:15 amRNSDirector/PDMR Shareholding
30th Jul 20247:00 amRNSTransaction in Own Shares
29th Jul 20247:00 amRNSTransaction in Own Shares
26th Jul 20247:10 amRNSShare Buyback Programme – 26 July 2024
26th Jul 20247:00 amRNSTrading Update and Return of Value – 26 July 2024
2nd Jul 202410:00 amRNSDirectorate Change -Confirmation of Effective Date
5th Jun 20247:00 amRNSCapital Markets Day
14th May 20242:00 pmRNSResult of AGM
1st May 20247:00 amRNSQ1 Trading Update
11th Apr 20241:00 pmRNS2023 Annual Financial Report & Notice of 2024 AGM
5th Apr 20247:00 amRNSDirectorate Change - Holding Announcement
4th Apr 20243:00 pmRNSDirector/PDMR Shareholding
27th Mar 20241:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20244:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20247:00 amRNSChange of Chair
20th Mar 20247:00 amRNSFinal Results 2023
5th Feb 20241:00 pmRNSBlock listing Interim Review
24th Jan 20247:00 amRNSPre-Close Trading Statement
30th Oct 202311:00 amRNSQ3 2023 Trading Update Replacement
30th Oct 20237:05 amRNSAppointment of Corporate Broker
30th Oct 20237:00 amRNSQ3 2023 Trading Update
17th Oct 20231:00 pmRNSDirector/PDMR Shareholding
12th Sep 202311:00 amRNSDirector/PDMR Shareholding
8th Sep 20237:00 amRNSHalf-year Report
8th Aug 202311:30 amRNSBlock listing Interim Review
14th Jun 202312:00 pmRNSHolding(s) in Company
7th Jun 202312:00 pmRNSDirector/PDMR Shareholding
6th Jun 20234:00 pmRNSDirector/PDMR Shareholding
17th May 20232:00 pmRNSResult of AGM
28th Apr 20237:00 amRNSQ1 2023 Trading Update
17th Apr 20231:31 pmRNS2022 Annual Financial Report & Notice of 2023 AGM
11th Apr 20233:15 pmRNSDirector/PDMR Shareholding
4th Apr 20234:00 pmRNSDirector/PDMR Shareholding
31st Mar 20231:00 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSFinal Results 2022
28th Mar 20237:00 amRNSFY2022 results release date - UPDATE
14th Mar 20237:00 amRNSFY2022 results revised date; guidance unchanged
2nd Mar 202310:00 amRNSHolding(s) in Company
17th Feb 202310:00 amRNSHolding(s) in Company
9th Feb 20239:30 amRNSHolding(s) in Company
6th Feb 202311:15 amRNSBlock listing Interim Review
30th Jan 20237:00 amRNSPre-Close Trading Statement
9th Dec 202212:30 pmRNSDirectorate Change - Update
9th Dec 202212:00 pmRNSChange of Auditor

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.